Insulet Corporation (PODD): SVP and General Counsel sold ~$1.68M
John W. Kapples, SVP and General Counsel at Insulet Corporation, sold ~$1.68M of Insulet Corporation shares.
- ~$1.68M
- Approx. value · 5,278 sh @ $318.47
- 23K
- Holds after · shares reported
- Traded
- May 14, 2025
- Filed
- May 15, 2025
What stands out in this filing
- The sale was 18.5% of the shares this insider held before it; the filing reports 23,180 shares afterwards.
- 5,278 shares at an average of $318.47 each, as reported on the form.
- No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jan 3, 2023CongressDisclosed purchase of PODD — reported range $1,001 - $15,000
- Jan 4, 2024CongressDisclosed sale of PODD — reported range $1,001 - $15,000
- Mar 25, 2025InsiderDirector sold ~$502K of PODD shares in the open market
- May 13, 2025Insider · 2 peopleInsiders: 2 sales (~$2.6M)
- May 14, 2025 · this disclosureInsiderOfficer sold ~$1.68M of PODD shares in the open market
What came next
- May 23, 2025FDARecall: Omnipod 5 Automated Insulin Delivery System, iOS Application. Model Number: PT-000664/M009-S-AP. Software Version: all Product Description: The Omnipod 5 iOS A…
- Jun 9, 2025InsiderDirector sold ~$147K of PODD shares in the open market
- Jun 13, 2025Insider · 2 peopleInsiders: 2 sales (~$1.1M)
- Aug 7, 2025InsiderOfficer sold ~$430K of PODD shares in the open market
- Aug 21, 2025InsiderOfficer sold ~$1.42M of PODD shares in the open market
- Sep 8, 2025Insider · 2 peopleInsiders: 2 sales (~$517K)
- Sep 11, 2025FDARecall: The failure occurs if a user on the Omnipod 5 iOS application selects and holds down on a manual entry field, to magnify the visual field using the magnifying…
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Insulet Corporation
For Insulet Corporation, OQRO holds 3 Congress trade reports and 3 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PODD page.
How this filing works
Explore the data
Common questions
Which Insulet Corporation (PODD) insider traded, and how much?
John W. Kapples, SVP and General Counsel at Insulet Corporation, sold ~$1.68M of Insulet Corporation shares. 5,278 shares at $318.47.
When did it happen, and when was it made public?
Traded: May 14, 2025. Filed: May 15, 2025. That is 1 day between the two dates.
What stands out in this filing?
The sale was 18.5% of the shares this insider held before it; the filing reports 23,180 shares afterwards. 5,278 shares at an average of $318.47 each, as reported on the form. No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Insulet Corporation recently?
For Insulet Corporation, OQRO holds 3 Congress trade reports and 3 fund holdings reports (13F) dated in the last 90 days. They are listed on the PODD page.
Does this mean PODD stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Insulet Corporation
- SEC Form 13F-HRNov 16, 2026
- SEC Schedule 13GNov 16, 2026
- SEC Schedule 13GNov 13, 2026
- House Clerk periodic transaction reportNov 10, 2026
- House Clerk periodic transaction reportOct 12, 2026
- House Clerk periodic transaction reportSep 10, 2026
Everything OQRO holds on this company is on its PODD page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data